Article

Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes

2015-01-01

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 576689d3-0f58-5060-9b66-c72917f49c40
DOI: 10.1186/2051-1426-3-s2-o2
PMCID: PMC4645288

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest

Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytesDOI 10.1186/2051-1426-3-s2-o2Read

PD-1 expression conditions T cell avidity within an antigen-specific repertoireSemantic proximity Read

Fingerprinting the circulating repertoire of antibodies from cancer patientsSemantic proximity Read

Human prostate‐infiltrating CD8 <sup>+</sup> T lymphocytes are oligoclonal and PD‐1 <sup>+</sup>Semantic proximity Read

Cancer-Homing CAR-T Cells and Endogenous Immune Population DynamicsSemantic proximity Read

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patientsSemantic proximity Read

Phenotypic characterization and function of tumor infiltrating and peripheral B cells in cancer patients.Semantic proximity Read

PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumorsSemantic proximity Read

The promise of circulating tumor cell analysis in cancer managementSemantic proximity Read